Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 310-320

  Olivares, Marta ^a   Laparra, Moisés ^a   Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Bifidobacterium longum; Celiac disease; Probiotic; Proteome; Weanling rats

Indexed keywords

GAMMA INTERFERON; GLIADIN; PROBIOTIC AGENT; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; CELIAC DISEASE; CELL MOTILITY; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; INFLAMMATION; JEJUNUM; LIPID METABOLISM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEWBORN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIVIRAL AGENTS; BIFIDOBACTERIUM; CELIAC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GLIADIN; HUMANS; INFANT; INTERFERON-GAMMA; INTESTINAL MUCOSA; JEJUNUM; MALE; PROBIOTICS; PROTEOME; RATS; RATS, WISTAR;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM LONGUM; RATTUS; TRITICUM AESTIVUM;

EID: 84870390001     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.005     Document Type: Article

References (41)

1. Di Sabatino A., Corazza G.R. Coeliac disease. Lancet 2009, 373:1480-1493.
2. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
3. Castellanos-Rubio A., Santin I., Irastorza I., Castano L., Carlos Vitoria J., Ramón Bilbao J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 2009, 42:69-73.
4. Kleinschek M.A., Boniface K., Sadekova S., Grein J., Murphy E.E., Turner S.P., et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009, 206:525-534.
5. Skovbjerg H., Anthonsen D., Knudsen E., Sjöström H. Deamidation of gliadin peptides in lamina propria: implications for celiac disease. Dig Dis Sci 2008, 53:2917-2924.
6. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signalling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2011, 21:357-366.
7. González S., Rodrigo L., López-Vázquez A., Fuentes D., Agudo-Ibáñez L., Rodríguez-Rodero S., et al. Association of MHC class I related gene B (MICB) to celiac disease. Am J Gastroenterol 2004, 99(4):676-680.
8. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
9. Troncone R., Ferguson A. Animal model of gluten induced enteropathy in mice. Gut 1991, 32:871-875.
10. Stěpanková R., Tlaskalová H., Šinkora J., Jodl J., Frič P. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand J Gastroenterol 1996, 31:551-557.
11. D'Arienzo R., Maurano F., Lavermicocca P., Ricca E., Rossi M. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 2009, 48:254-259.
12. Laparra J.M., Olivares M., Gallina O., Sanz Y. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 2012, 7:e30744.
13. Black K.E., Murray J.A., David C.S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 2002, 169:5595-5600.
14. Verdu E.F., Huang X., Natividad J., Lu J., Blennerhassett P.A., David C.S., et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol 2008, 294:217-225.
15. Sanz Y., Marcos A. Dietary strategies of immunomodulation in infants at risk for celiac disease. Proc Nutr Soc 2010, 69:347-353.
16. Olivares M., Laparra M., Sanz Y. Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal epithelial cell proteome. J Agric Food Chem 2011, 59:7666-7671.
17. Lammers K.M., Lu R., Brownley J., Lu B., Gerard C., Thomas K., et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008, 135:194-204.
18. Simula M.P., Cannizzaro R., Canzonieri V., Pavan A., Maiero S., Toffoli G., et al. PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med 2010, 16:199-209.
19. Laparra J.M., Sanz Y. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modification of toxic peptide generation during digestion. J Cell Biochem 2010, 109:801-807.
20. Lovett-Racke A.E., Hussain R.Z., Northrop S., Choy J., Rocchini A., Matthes L., et al. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 2004, 172:5790-5798.
21. Dubuquoy L., Rousseaux C., Thuru X., Peyrin-Biroulet L., Romano O., Chavatte P., et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006, 55:1341-1349.
22. Yan J.X., Wait R., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3672.
23. D'Arienzo R., Stefanile R., Maurano F., Mazzarella G., Ricca E., Troncone R., et al. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand J Immunol 2011, 74:335-341.
24. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000, 1:11-21.
25. Zhang M., Leung F.P., Huang Y., Bian Z.X. Increased colonic motility in a rat model of irritable bowel syndrome is associated with up-regulation of L-type calcium channels in colonic smooth muscle cells. Neurogastroenterol Motil 2010, 22:162-170.
26. Tones M.A., Sharif N.A., Hawthorne J.N. Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells. Mitogenesis without phosphoinositide breakdown. Biochem J 1988, 249:51-56.
27. Berridge M.J., Irvine R.F. Inositol phosphates and cell signalling. Nature 1989, 341:197-205.
28. Henslee J.G., Jones M.E. Ornithine synthesis from glutamate in rat small intestinal mucosa. Arch Biochem Biophys 1982, 219:186-197.
29. Wang Y., Barbaro M.F., Baraban S.C. A role for the mTOR pathway in surface expression of AMPA receptors. Neurosci Lett 2006, 401:35-39.
30. Beevers C., Li F., Liu L., Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Cancer 2006, 119:757-764.
31. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
32. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002, 122:531-544.
33. Reinke Y., Behrendt M., Schmidt S., Zimmer K.P., Naim H.Y. Impairment of protein trafficking by direct interaction of gliadin peptides with actin. Exp Cell Res 2011, 317:2124-2135.
34. Holmgren Peterson K., Magnusson K.E., Stenhammar L., Fälth-Magnusson K. Confocal laser scanning microscopy of small-intestinal mucosa in celiac disease. Scand J Gastroenterol 1995, 30:228-234.
35. Maples C.J., Ruiz W.G., Apodaca G. Both microtubules and actin filaments are required for efficient postendocytotic traffic of the polymeric immunoglobulin receptor in polarized Madin-Darby canine kidney cells. J Cell Biochem 1997, 272:6741-6751.
36. Kutnezsov S.A., Langford G.M., Weiss D.G. Actin-dependent organelle movement in squid axoplasm. Nature 1992, 356:722-735.
37. Viatour P., Merville M.P., Bours V., Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005, 30:43-52.
38. Zimmer K.P., Fischer I., Mothes T., Weissen-Plenz G., Schimtz M., Wiesser H., et al. Endocytic segregation of gliadin peptide 31-49 in enterocytes. Gut 2010, 59:300-310.
39. Barone M.V., Zanzi D., Maglio M., Nanayakkara M., Santagata S., Lania G., et al. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking 2011. PLoS One 2011, e17039.
40. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999, 20:649-688.
41. Sankaranarayanan S., Ma Y., Bryson M., Li N., Ross A.C. Neonatal-age treatment with vitamin A delays postweaning vitamin A deficiency and increases the antibody response to T-cell dependent antigens in Young adult rats fed a vitamin A-deficient diet. J Nutr 2007, 137:1229-1235.